Calidi Biotherapeutics
78 posts
Calidi Biotherapeutics
@CalidiBio
Novel oncology platform targeting solid tumors with precision virotherapy. Building toward clinical validation. NYSEAMERICAN: $CLDI
🦠Can viruses become medicines? 🚀 For decades, viruses have been viewed as enemies. But what if the same biological machinery that allows viruses to invade cells could be re-engineered to fight cancer? In this fascinating @ProgressPotent1 conversation, I sit down with Dr. Eric Poma, Ph.D. - CEO of @CalidiBio, to explore a new generation of targeted genetic medicines and oncolytic virotherapy. We discuss: 🧬 Why drug delivery may be the biggest bottleneck in oncology; 🦠 How engineered vaccinia viruses are being designed to reach metastatic tumors; 🎯 The science behind Calidi's RedTail platform and CLD-401 ⚔️ Using IL-15 to activate the immune system directly inside tumors; 🔬 Tumor-selective viral amplification and the challenge of systemic delivery; 🤖 AI-enabled drug development and IND workflows; 🌎 What the future of cancer therapy could look like if tumors themselves become localized drug factories; From virology and immunology to synthetic biology and precision medicine, this episode explores one of the most intriguing frontiers in oncology. Watch now - youtube.com/watch?v=LHGciT… #CancerResearch #Oncology #Immunotherapy #GeneTherapy #Biotechnology #CancerTreatment #PrecisionMedicine #OncolyticVirus #SyntheticBiology #GeneticMedicine #DrugDelivery #MetastaticCancer #FutureOfMedicine #Biopharma #EricPoma #CalidiBiotherapeutics #ProgressPotentialPossibilities @CoreIR_
Top scientists and Pfizer’s former CMO are backing Calidi Biotherapeutics (New York Stock Exchange American: $CLDI). Why? Because its systemic genetic delivery platform could redefine how we treat cancer. 🎥 Watch our 30-sec investor overview. 🔗 redchip.news/4nLmPXR $CLDI $PFE $AMGN $JNJ $CADL $BMRN $CPRX $CGON $REPL $NBTX $IBRX
